Patent ID: 9079009
Filing Date: 2015-07-14
Classification: A61H,A61N,A61P,F04C

Abstract:
1. A method for disrupting or destroying selected pathogens selected from the group comprising Herpes Simplex virus I, Herpes Simplex virus II, and Staphylococcus Aureus located within the body of an organism including the steps of: selecting a pathogen to be disrupted, with each pathogen being subjected to intensity of a low intensity ultrasonic energy to a value distribution substantially limited within predefined ranges of frequencies, wherein the predefined ranges of frequencies are: 291 to 293 kHz and 345 to 346 kHz, where a selected pathogen is Herpes Simplex virus I; 353 to 354 kHz and 362 to 363 kHz, where a selected pathogen is Herpes Simplex virus II; and 376 to 377 kHz and 380 to 381 kHz, where a selected pathogen is non-invasively administering an amount of the low intensity ultrasonic energy to a treatment location on or in the organism, wherein the treatment location is a ganglia, where the selected pathogen is Herpes Simplex viruses I or II or a site of infection, where the selected pathogen is disrupting or destroying the selected pathogen while not deleteriously affecting the organism.